Is there a place for immunomodulation in assisted reproduction techniques?
We briefly review the history of the concepts of the materno foetal relationship, and the (various) rationales which have been used to justify lymphocyte alloimmunisation (LA) as a treatment for recurrent spontaneous abortion of putative immune origins. The effectiveness of the treatment is at best dubious and limited to a small number of women for which there is no real positive selection rationale, at worst it is not efficient. The rationales themselves are rather "evolutive". The present one is to use the Th1:Th2 paradigm and, thus, to propose to "dampen NK activity" in abortion prone women and this concept has been extended by some to implantation failure. We briefly review why the Th1:Th2 paradigms is no longer fully valid, describe briefly why it is inappropriate for implantation, and conclude that alloimmunisation should no longer be proposed for RSA, hence, more for implantation failure. We, however, do not reject immunotherapy, but we believe that molecular and cellular defects specific approaches should be used, tailored for the specific pathway whose disruption cause the clinical symptom.
U131 INSERM, Hospital Antoine Béclère, Avenue de lat Porte de Trivaux, Clamart 92141, France. gerard_chaouat@wanadoo.fr
Gerard
G
Chaouat
Natalie
N
Ledee-bataill
Sylvie
S
Dubanchet
D000022:Abortion, Spontaneous / Q000276:immunology / Q000628:therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007167:Immunotherapy / Q000379:methods; D011247:Pregnancy; D027724:Reproductive Techniques, Assisted; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology / Q000637:transplantation
D007155:Immunologic Factors